# US 2019/0208800 A1 · L-glutamine in swine diets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0208800 A1
- Document ID: US20190208800A1
- Status: Published application
- Kind: A1
- Application number: 16/224,886
- Filed: 2018-12-19
- Published: 2019-07-11
- Earliest claimed: 2018-01-05
- Applicants: The United States of America, as represented by the Secretary of Agriculture
- Inventors: Jay S. Johnson
- Web page: https://patentgrep.com/patent/US20190208800A1

## CPC

- A23K 20/142: Amino acids; Derivatives thereof
- A23K 50/30: for swines
- A23K 50/60: for weanlings
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2200/31: having an effect on comfort perception and well-being
- A23V 2200/324: having an effect on the immune system
- A23V 2250/062: Glutamine
- A61P 37/02: Immunomodulators
- A23K: FODDER
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A swine feed may include a non-antibiotic immunomodulator, for example L-glutamine. The use of such a diet may include feeding it to piglets post-weaning and transportation to alleviate some of the negative effects of such stressors on pig production and welfare. Use of L-glutamine in the piglets' diet may have several beneficial effects, such as the reduction of enteric disease and faster weight gain. The use of L-glutamine may be a cost-effective replacement for traditional dietary antibiotics in swine production.

## Claims

### Claim at position 1

1: A composition of swine feed comprising a therapeutically effective amount of a non-antibiotic immunomodulator.

### Claim at position 2 (depends on 1)

2: The composition of claim 1, wherein the non-antibiotic immunomodulator is also a growth promotant.

### Claim at position 3 (depends on 1)

3: The composition of claim 1, wherein the non-antibiotic immunomodulator is L-glutamine.

### Claim at position 4 (depends on 1)

4: The composition of claim 1, wherein the non-antibiotic immunomodulator is present in an amount of about 0.10%-1.0% (w/w) as compared to the total amount of the swine feed.

### Claim at position 5 (depends on 4)

5: The composition of claim 4, wherein the non-antibiotic immunomodulator is present in an amount of about 0.20%-0.60% as compared to the total amount of the swine feed.

### Claim at position 6

6: A method of decreasing negative effects of a stressor on swine, the method comprising:
providing the swine with a first swine feed, the first swine feed comprising a therapeutically effective amount of a non-antibiotic immunomodulator,
wherein the swine is provided with the first swine feed during a period before, during, or after the stressor is introduced to the swine.

### Claim at position 7 (depends on 6)

7: The method of claim 6, wherein the non-antibiotic immunomodulator is also a growth promotant.

### Claim at position 8 (depends on 6)

8: The method of claim 6, wherein the non-antibiotic immunomodulator is L-glutamine.

### Claim at position 9 (depends on 6)

9: The method of claim 6, wherein the stressor is one of weaning and transportation.

### Claim at position 10 (depends on 6)

10: The method of claim 6, wherein the swine is provided with the first swine feed during a period of at least 14 days after the stressor is introduced.

### Claim at position 11 (depends on 6)

11: The method of claim 6, wherein the negative effects are the incidence of enteric disease in the swine.

### Claim at position 12 (depends on 6)

12: The method of claim 6, further comprising providing the swine with a second swine feed,
wherein the second swine feed does not contain the non-antibiotic immunomodulator, and
wherein the swine is provided with the first swine feed during a treatment period, and after the treatment period elapses the swine is provided with the second swine feed during a growth period.

### Claim at position 13 (depends on 12)

13: The method of claim 12, wherein the treatment period is about 14 days in length.
